S 9 to 16 along with the splicing acceptor site and 39-UTR at the downstream of exon 8 successfully restored the expression of MSH2 (Fig. 1 and 3). The expression of MSH2 stabilized MSH6, which is unstable in the absence of MSH2, and recovered mismatch repair functions. The spontaneous HPRT mutation frequency was reduced more than 25-fold by the expression of MSH2/MSH6. The cells expressing MSH2/ MSH6, which we call Nalm-6-MSH+, was more sensitive to the killing effects of MNNG than the original Nalm-6 cells in the presence of O6-BG (Fig. 4). These results suggest that the expressed MSH2 acts as a component of mismatch repair and Fexinidazole functions as a sensor of DNA damage. The established Nalm-6-MSH+ is more appropriate to examine mutagenicity of genotoxic agents than the original Nalm-6 cells. Mismatch repair is in general regarded as an inhibitory factor for homologous recombination, which plays a key role in gene targeting (27, 28). The repair enzymes recognize and correct mismatch bases in heterodulplex 
DNA generated during recombination. It is expected that targeting efficiency with vectors having divergent DNA sequences from the chromosome might be lowered by the presence of mismatch repair systems. In fact, HCT116 human cells, which are sometimes used for gene targeting, are deficient in MLH1, another component of mismatch repair [29]. Thus, we were anxious initially that the recovery of MSH2 expression might reduce targeting efficiency of Nalm-6 cells. As a matter of fact, however, the expression of MSH2 did not suppress gene targeting efficiency with HPRT in the cells (Table 1). In addition, MSH2 did not reduce the efficiency with vectors having mismatch sequences in 59-arm, which is basically homologous to the chromosome (Table 2). These results suggest that the established 11967625 Nalm-6-MSH+, can be employed in gene targeting with efficiency as much as the original Nalm-6. The reason(s) why mismatch repair did not reduce the targeting efficiency is unclear. However, it is suggested that mismatches in the homology regions of targeting vectors are not seriously SIS 3 site deleterious when the percentage of mismatches against the whole homology regions is less than 1 [30]. In the experiments, the percentage of mismatches in the restriction sites against 59homology arm of HPRT was 0.5 (11 bps/2,398 bps). REV3L is the gene encoding the catalytic subunit of 
DNA polymerase f, which is a specialized DNA polymerase involved in DNA synthesis across DNA lesions [31]. We chose 15755315 this gene as an actual target for gene replacement in Nalm-6-MSH+ because the polymerase is expected to be involved in TLS of a variety of genotoxic agents [32]. In addition, the polymerase interacts with multiple other proteins, e.g., REV7/MAD2L2, MAD2 [33,34] and is twice the size of the yeast homolog mainly because of one exon encoding about 1400 amino acids [35,36]. Therefore, we speculate that REV3L might have structural roles in defense mechanisms against DNA damaging agents by interacting with other proteins. To distinguish the catalytic and structural roles of DNA polymerase f in TLS and other defense mechanisms, weKnockout and Knock-in of the REV3L Gene in Nalm-6MSH+ CellsTo further demonstrate that Nalm-6-MSH+ cells are useful for gene targeting, we established heterozygous REV3L knockout or knock-in cell lines (Table 3). The knockout cell line was generated by replacement of exon 5 of REV3L with the hygromycinresistance gene (Fig. 7A). The knock-in mutation was introduced into.S 9 to 16 along with the splicing acceptor site and 39-UTR at the downstream of exon 8 successfully restored the expression of MSH2 (Fig. 1 and 3). The expression of MSH2 stabilized MSH6, which is unstable in the absence of MSH2, and recovered mismatch repair functions. The spontaneous HPRT mutation frequency was reduced more than 25-fold by the expression of MSH2/MSH6. The cells expressing MSH2/ MSH6, which we call Nalm-6-MSH+, was more sensitive to the killing effects of MNNG than the original Nalm-6 cells in the presence of O6-BG (Fig. 4). These results suggest that the expressed MSH2 acts as a component of mismatch repair and functions as a sensor of DNA damage. The established Nalm-6-MSH+ is more appropriate to examine mutagenicity of genotoxic agents than the original Nalm-6 cells. Mismatch repair is in general regarded as an inhibitory factor for homologous recombination, which plays a key role in gene targeting (27, 28). The repair enzymes recognize and correct mismatch bases in heterodulplex DNA generated during recombination. It is expected that targeting efficiency with vectors having divergent DNA sequences from the chromosome might be lowered by the presence of mismatch repair systems. In fact, HCT116 human cells, which are sometimes used for gene targeting, are deficient in MLH1, another component of mismatch repair [29]. Thus, we were anxious initially that the recovery of MSH2 expression might reduce targeting efficiency of Nalm-6 cells. As a matter of fact, however, the expression of MSH2 did not suppress gene targeting efficiency with HPRT in the cells (Table 1). In addition, MSH2 did not reduce the efficiency with vectors having mismatch sequences in 59-arm, which is basically homologous to the chromosome (Table 2). These results suggest that the established 11967625 Nalm-6-MSH+, can be employed in gene targeting with efficiency as much as the original Nalm-6. The reason(s) why mismatch repair did not reduce the targeting efficiency is unclear. However, it is suggested that mismatches in the homology regions of targeting vectors are not seriously deleterious when the percentage of mismatches against the whole homology regions is less than 1 [30]. In the experiments, the percentage of mismatches in the restriction sites against 59homology arm of HPRT was 0.5 (11 bps/2,398 bps). REV3L is the gene encoding the catalytic subunit of DNA polymerase f, which is a specialized DNA polymerase involved in DNA synthesis across DNA lesions [31]. We chose 15755315 this gene as an actual target for gene replacement in Nalm-6-MSH+ because the polymerase is expected to be involved in TLS of a variety of genotoxic agents [32]. In addition, the polymerase interacts with multiple other proteins, e.g., REV7/MAD2L2, MAD2 [33,34] and is twice the size of the yeast homolog mainly because of one exon encoding about 1400 amino acids [35,36]. Therefore, we speculate that REV3L might have structural roles in defense mechanisms against DNA damaging agents by interacting with other proteins. To distinguish the catalytic and structural roles of DNA polymerase f in TLS and other defense mechanisms, weKnockout and Knock-in of the REV3L Gene in Nalm-6MSH+ CellsTo further demonstrate that Nalm-6-MSH+ cells are useful for gene targeting, we established heterozygous REV3L knockout or knock-in cell lines (Table 3). The knockout cell line was generated by replacement of exon 5 of REV3L with the hygromycinresistance gene (Fig. 7A). The knock-in mutation was introduced into.
